Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,037,179,923.19
- March 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 29, 2022 | Director | 621 | $278.77 | Sell | $173,116.17 | |
| July 25, 2022 | Chairman | 132,079 | $281.38 | Sell | $37,164,389.02 | |
| July 19, 2022 | EVP | 17,865 | $288.65 | Sell | $5,156,732.25 | |
| June 24, 2022 | CEO | 11,689 | $291.30 | Sell | $3,405,005.70 | |
| May 4, 2022 | EVP | 36 | $275.09 | Sell | $9,903.24 | |
| May 2, 2022 | EVP | 320 | $259.16 | Sell | $82,931.20 | |
| May 2, 2022 | CFO | 343 | $258.83 | Sell | $88,778.69 | |
| May 2, 2022 | COO | 306 | $263.98 | Sell | $80,777.88 | |
| May 2, 2022 | Director | 737 | $258.94 | Sell | $190,838.78 | |
| April 29, 2022 | SVP | 120 | $275.41 | Sell | $33,049.20 | |
| April 25, 2022 | CAO | 327 | $269.55 | Sell | $88,142.85 | |
| April 18, 2022 | Director | 2,000 | $284.23 | Sell | $568,460.00 | |
| April 13, 2022 | Director | 2,000 | $287.50 | Sell | $575,000.00 | |
| April 13, 2022 | Chairman | 15,789 | $289.04 | Sell | $4,563,652.56 | |
| April 11, 2022 | Director | 2,000 | $280.30 | Sell | $560,600.00 | |
| April 7, 2022 | Director | 2,000 | $274.86 | Sell | $549,720.00 | |
| April 7, 2022 | EVP | 561 | $276.18 | Sell | $154,936.98 | |
| April 4, 2022 | Director | 2,000 | $267.72 | Sell | $535,440.00 | |
| April 4, 2022 | EVP | 562 | $267.71 | Sell | $150,453.02 | |
| April 1, 2022 | CFO | 2,582 | $264.76 | Sell | $683,610.32 | |
| March 31, 2022 | Director | 5,000 | $262.27 | Sell | $1,311,350.00 | |
| March 17, 2022 | CFO | 3,171 | $250.15 | Sell | $793,225.65 | |
| March 17, 2022 | EVP | 2,833 | $250.11 | Sell | $708,561.63 | |
| Feb. 25, 2022 | EVP | 325 | $230.95 | Sell | $75,058.75 | |
| Feb. 18, 2022 | EVP | 519 | $231.00 | Sell | $119,889.00 | |
| Feb. 11, 2022 | EVP | 2,297 | $235.02 | Sell | $539,840.94 | |
| Feb. 2, 2022 | CFO | 2,944 | $250.07 | Sell | $736,206.08 | |
| Feb. 2, 2022 | EVP | 1,040 | $250.98 | Sell | $261,019.20 | |
| Jan. 28, 2022 | Director | 5,000 | $241.79 | Sell | $1,208,950.00 | |
| Nov. 15, 2021 | EVP | 51 | $187.19 | Sell | $9,546.69 | |
| Nov. 15, 2021 | COO | 3 | $187.26 | Sell | $561.78 | |
| Aug. 19, 2021 | CEO | 10,000 | $195.65 | Buy | $1,956,500.00 | |
| June 2, 2021 | Director | 559 | $209.69 | Sell | $117,216.71 | |
| May 3, 2021 | EVP | 960 | $218.43 | Sell | $209,692.80 | |
| April 27, 2021 | EVP | 3,884 | $216.06 | Sell | $839,177.04 | |
| April 5, 2021 | EVP | 1,686 | $214.14 | Sell | $361,040.04 | |
| Feb. 11, 2021 | EVP | 1,686 | $210.56 | Sell | $355,004.16 | |
| Feb. 11, 2021 | CAO | 1,498 | $210.57 | Sell | $315,433.86 | |
| Feb. 5, 2021 | EVP | 1,930 | $215.00 | Sell | $414,950.00 | |
| Feb. 3, 2021 | EVP | 400 | $216.56 | Sell | $86,624.00 | |
| Nov. 10, 2020 | Director | 15,000 | $217.36 | Buy | $3,260,400.00 | |
| Nov. 3, 2020 | EVP | 1,553 | $211.92 | Sell | $329,111.76 | |
| Oct. 5, 2020 | Director | 10,516 | $266.79 | Sell | $2,805,563.64 | |
| Aug. 3, 2020 | EVP | 1,941 | $278.28 | Sell | $540,141.48 | |
| July 13, 2020 | EVP | 2,125 | $292.05 | Sell | $620,606.25 | |
| July 13, 2020 | SVP | 860 | $292.03 | Sell | $251,145.80 | |
| July 10, 2020 | CFO | 700 | $293.15 | Sell | $205,205.00 | |
| July 7, 2020 | EVP | 2,786 | $300.00 | Sell | $835,800.00 | |
| June 30, 2020 | Chairman | 32,792 | $286.15 | Sell | $9,383,430.80 | |
| May 12, 2020 | Chairman | 94,370 | $283.47 | Sell | $26,751,063.90 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Kristen Ambrose, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Jonathan Biller, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Jeffrey Leiden, Edward Morrow Atkinson III, Wayne Joseph Riley, Thomas Graney, Mark E Bunnage, Paul Silva, Christiana Stamoulis, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, Kenneth Horton, Paul M. Silva, Ian F. Smith, William D Young, Duncan Mckechnie, and Sangeeta N. Bhatia
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.